Skip to main content English


Dr. med. univ. Markus Kieler

Department of Medicine I (Division of Palliative Medicine)


Carcinoma, Pancreatic Ductal; Immune System; Medical Oncology; Palliative Care; Parenteral Nutrition

Research group(s)

Selected publications

  1. Kieler, M. et al. (2022) ‘C-reactive protein and white blood cell count are adverse prognostic markers for patients with advanced cancer on parenteral nutrition in a palliative care unit setting: A retrospective cohort study’, Palliative Medicine, 36(3), pp. 540–548. Available at:
  2. Kum, L. et al. (2022) ‘Kidney Function Worsening Is Linked to Parenteral-Nutrition-Dependent Survival in Palliative Care Patients’, Nutrients, 14(4), p. 769. Available at:
  3. Kieler, M. et al. (2020) ‘Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients’, Journal of Clinical Medicine, 9(3), p. 648. Available at:
  4. Kieler, M. et al. (2019) ‘A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid’, Therapeutic Advances in Medical Oncology, 11, p. 175883591985319. Available at:
  5. Kieler, M. et al. (2018) ‘Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy’, Medical Oncology, 36(1). Available at: